Open-Access Research

Advanced Platforms for Target Validation

IDDI provides state-of-the-art assay platforms and structural biology facilities, bridging academic discoveries with clinical candidate development. Access our robust infrastructure to accelerate your translational research.

Core Infrastructure

Integrated Systems for Drug Discovery

Screening

High-Throughput Assay Arrays

Automated systems for rapid, unbiased screening of compound libraries against novel biological targets, ensuring precision and scalability.

Structure

Cryo-Electron Microscopy Facilities

Access to advanced cryo-EM for high-resolution structural determination of protein targets, critical for rational drug design and optimization.

Analysis

Molecular Profiling Systems

Comprehensive platforms for detailed molecular characterization, including metabolomics and proteomics, to validate target engagement and mechanism of action.

Our Methodology

From Target to Validated Lead

01
02
03
04

Target Submission & Review

Assay Optimization & Development

High-Content Screening Campaigns

Data Validation & Lead Prioritization

Submit novel biological targets for evaluation by our scientific advisory board, assessing therapeutic potential and assayability.

Collaborative optimization of biochemical and cell-based assays to ensure robustness and suitability for high-throughput screening.

Execution of screening campaigns utilizing our extensive compound libraries and advanced automated platforms to identify initial hits.

Rigorous validation of identified hits, followed by molecular profiling and structural analysis to prioritize lead candidates for further development.

Accelerate Your Research with IDDI

Partner with IDDI to leverage open-access platforms and expert guidance. Submit your target proposals or request detailed data access protocols.